A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma.

Br J Cancer · 2009 · PMC2695693 · PMID 19436301

Europe PMC DOI

hedged sentences

0.2000

closest p · 4.0× alpha

0.2000

boldest claim

The sentences

a nonsignificant trendP =0.2not close (p > 0.1)

Overall survival according to R resection status for the 26 resected patients is shown in Figure 2 and indicates a nonsignificant trend for improved survival in the R0 vs R1 group (HR 2.1; 95% CI 0.7–7.0; P =0.2).

also in 5,406 other papers

did not reach statistical significanceno p-value reported

In this study, there was a trend towards improved survival for patients achieving an R0 compared with an R1 resection, which did not reach statistical significance and is likely to reflect the small patient numbers.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.